Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2025-03-26 Purchase |
2025-03-28 5:34 pm |
Oncology Institute Inc. | TOI | Hively Brad Director |
9,056 | $1.0417 | $9,434 | 680,337 (Direct) |
View |
2024-11-26 Purchase |
2024-12-02 4:04 pm |
Oncology Institute Inc. | TOI | Hively Brad Director |
300,000 | $0.16667 | $50,000 | 1,020,203 (Direct) |
View |
2024-06-17 Sale |
2024-06-20 4:17 pm |
Oncology Institute Inc. | TOI | Hively Brad Director |
18,121 | $0.4578 | $8,296 | 676,203 (Direct) |
View |
2024-05-22 Sale |
2024-05-23 7:22 pm |
Oncology Institute Inc. | TOI | Hively Brad Director |
19,526 | $0.5753 | $11,233 | 694,324 (Direct) |
View |
2023-11-21 Sale |
2023-11-22 9:01 pm |
Oncology Institute Inc. | TOI | Hively Brad Director |
25,867 | $2.193 | $56,726 | 671,198 (Direct) |
View |
2023-11-17 Sale |
2023-11-21 7:27 pm |
Oncology Institute Inc. | TOI | Hively Brad Director |
25,000 | $2.24 | $56,000 | 2,442,496 (Direct) |
View |
2023-11-13 Sale |
2023-11-15 6:49 pm |
Oncology Institute Inc. | TOI | Hively Brad Director |
74,117 | $2.4736 | $183,336 | 2,467,496 (Direct) |
View |
2022-11-15 Sale(A) |
2022-11-22 8:07 pm |
Oncology Institute Inc. | TOI | Hively Brad Chief Executive Officer |
9,718 | $2.0278 | $19,706 | 452,201 (Direct) |
View |
2022-11-15 Sale |
2022-11-17 5:30 pm |
Oncology Institute Inc. | TOI | Hively Brad Chief Executive Officer |
9,718 | $2.0278 | $19,706 | 452,201 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2024-11-12 Other |
2024-12-02 4:04 pm |
N/A N/A |
Oncology Institute Inc. | TOI | Hively Brad Director |
353,450 | $0 | 1,020,203 (Direct) |
View |
2024-11-22 Option Award |
2024-11-25 4:14 pm |
N/A N/A |
Oncology Institute Inc. | TOI | Hively Brad Director |
44,000 | $0 | 720,203 (Direct) |
View |
2023-12-26 Option Award |
2023-12-28 5:46 pm |
N/A N/A |
Oncology Institute Inc. | TOI | Hively Brad Director |
42,652 | $0 | 713,850 (Direct) |
View |
2023-11-17 Exercise |
2023-11-21 7:27 pm |
N/A N/A |
Oncology Institute Inc. | TOI | Hively Brad Director |
25,000 | $0.85 | 2,442,496 (Direct) |
View |
2023-11-17 Exercise |
2023-11-21 7:27 pm |
N/A 2029-12-02 |
Oncology Institute Inc. | TOI | Hively Brad Director |
25,000 | $0 | 2,442,496 (Direct) |
View |
2023-11-13 Exercise |
2023-11-15 6:49 pm |
N/A N/A |
Oncology Institute Inc. | TOI | Hively Brad Director |
47,000 | $0.85 | 2,467,496 (Direct) |
View |
2023-11-13 Exercise |
2023-11-15 6:49 pm |
N/A 2029-12-02 |
Oncology Institute Inc. | TOI | Hively Brad Director |
47,000 | $0 | 2,467,496 (Direct) |
View |
2023-03-17 Option Award |
2023-03-21 8:44 pm |
N/A 2033-03-17 |
Oncology Institute Inc. | TOI | Hively Brad Chief Executive Officer |
589,792 | $0 | 1,145,462 (Direct) |
View |
2022-11-17 Option Award |
2022-11-21 5:31 pm |
N/A 2032-11-17 |
Oncology Institute Inc. | TOI | Hively Brad Chief Executive Officer |
628,657 | $0 | 1,080,858 (Direct) |
View |
2022-03-21 Option Award(A) |
2022-03-29 8:10 pm |
N/A 2032-03-21 |
Oncology Institute Inc. | TOI | Hively Brad Chief Executive Officer |
550,563 | $0 | 550,563 (Direct) |
View |
2022-03-21 Option Award |
2022-03-23 7:36 pm |
N/A 2032-03-21 |
Oncology Institute Inc. | TOI | Hively Brad Chief Executive Officer |
196,559 | $0 | 550,009 (Direct) |
View |
2021-11-12 Option Award(A) |
2021-11-18 8:25 pm |
N/A N/A |
Oncology Institute Inc. | TOI | Hively Brad Chief Executive Officer |
353,450 | $0 | 363,450 (Direct) |
View |
2021-11-12 Option Award |
2021-11-16 9:53 pm |
N/A 2029-12-02 |
Oncology Institute Inc. | TOI | Hively Brad Chief Executive Officer |
2,170,881 | $0 | 2,029,501 (Direct) |
View |